<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00524693</url>
  </required_header>
  <id_info>
    <org_study_id>HP-146-R</org_study_id>
    <nct_id>NCT00524693</nct_id>
  </id_info>
  <brief_title>Montelukast in Acute RSV Bronchiolitis</brief_title>
  <official_title>A Double-Blind Placebo Controlled Randomized Trial of Montelukast in Acute Respiratory Syncytial Virus Bronchiolitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ziv Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wolfson Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ziv Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is evidence of inflammatory mechanisms in RSV bronchiolitis with increased
      cysteinyl-leukotrienes (cys-LT). Recently, specific cys-LT receptor antagonists - montelukast
      (Singulair©) approved for use in infants as granule sachets, have become available. We
      evaluated the effect of Singulair© on clinical progress and on cytokine profiles in the acute
      phase of RSV bronchiolitis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of stay</measure>
    <time_frame>hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4mg Singulair© sachets</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Montelukast</intervention_name>
    <description>4mg sachets</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Singulair©</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo granules</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 4 weeks &lt; 2 years

          -  Duration of respiratory symptoms &lt; 4 days

          -  Signs of bronchiolitis: prodromal rhinorrhea and cough, followed by at least two of
             the following signs: chest retractions, tachypnea, wheezing, or rales

          -  First episode of wheezing or shortness of breath

          -  Randomization within 12 hours of admission

          -  No need for steroid treatment in the ward

          -  Informed consent

        Exclusion Criteria:

          -  A history of asthma symptoms or any previous hospital admissions with respiratory
             tract illnesses and if they had ever been treated with anti-asthma medications (prior
             to the current illness).

          -  Underlying cardiopulmonary disease such as bronchopulmonary dysplasia, congenital
             heart disease, immunodeficiency, or cystic fibrosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Israel Amirav, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ziv Medical Center</affiliation>
  </overall_official>
  <verification_date>September 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2007</study_first_submitted>
  <study_first_submitted_qc>September 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2007</study_first_posted>
  <last_update_submitted>September 4, 2007</last_update_submitted>
  <last_update_submitted_qc>September 4, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2007</last_update_posted>
  <keyword>Bronchiolitis</keyword>
  <keyword>controlled clinical trial</keyword>
  <keyword>pediatrics</keyword>
  <keyword>Infants</keyword>
  <keyword>montelukast</keyword>
  <keyword>Respiratory syncytial virus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Montelukast</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

